Translate this page into:
Right Ventricular Strain Secondary to Tumour-Induced Pulmonary Artery Obstruction: An Incidental 18F-FDG PET/CT Finding in Small Cell Pancoast Tumour
*Corresponding author: Dr. Harish Goyal, Department of Nuclear Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), PET Block JIPMER Campus, Puducherry- 605006, India harishgoyal.aiims@gmail.com
-
Received: ,
Accepted: ,
How to cite this article: Goyal H, Kumar SA, Narayanan S, Manikya YS, Halanaik D. Right Ventricular Strain Secondary to Tumour-Induced Pulmonary Artery Obstruction: An Incidental 18F-FDG PET/CT Finding in Small Cell Pancoast Tumour. Indian J Nucl Med. 2026;41:401-3. doi: 10.25259/IJNM_100_25.
Abstract
Right ventricular (RV) myocardial strain is a rare inflammatory response that occurs in response to acute RV pressure overload, often as a result of pulmonary hypertension (PH). We present a case involving a 65-year-old male with a small cell Pancoast tumour causing obstruction of the right upper pulmonary artery, resulting in PH and RV dilation. 18F-Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) revealed diffuse uptake of FDG in the RV myocardium, indicating RV myocardial strain. Echocardiography confirmed signs of PH, including significant RV dilation and strain patterns. This case highlights the importance of recognising RV myocardial strain as an incidental but crucial finding on 18F-FDG PET/CT, especially in cases of malignancy-associated PH.
Keywords
18F-fluorodeoxyglucose positron emission tomography/computed tomography
Pancoast tumour
Pulmonary hypertension
Right ventricular myocardial strain
Right ventricular strain
Small cell lung carcinoma
A 65-year-old male chronic smoker presented with right-sided ptosis, miosis, and anhidrosis, indicative of Horner syndrome. A magnetic resonance imaging revealed a mass in the apical region of the right lung, and a biopsy confirmed the diagnosis of small cell carcinoma. For initial staging, an 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) scan was performed. The scan revealed a large FDG-avid mass in the right upper lobe measuring 10.8 cm × 8.4 cm × 12.0 cm (anterior–posterior × transverse × craniocaudal) with a maximum standardised uptake value (SUVmax) of 12.8 [Fig 1a-f]. The mass is infiltrating the pleura and chest wall and encasing the right subclavian artery [Fig 1e]. Furthermore, the scan showed a few metabolically active mediastinal lymph nodes, particularly in the right lower paratracheal region, with an SUVmax of 2.4. In addition, there was a left parietotemporal brain lesion measuring 4.0 cm × 2.7 cm × 3.0 cm, with peripheral FDG uptake and an SUVmax of 3.7 and significant perilesional oedema [Fig 1a, g-i]. Notably, the tumour obstructed the right upper segmental pulmonary artery [Fig 1e], which led to pulmonary hypertension (PH) and subsequent right heart strain. Cardiac findings included diffuse increased FDG uptake in the right ventricular (RV) myocardium (SUVmax 4.9), marked right ventricular dilation, right atrial enlargement, and pulmonary trunk enlargement [Fig 1f, j–l].

Echocardiography confirmed these findings, displaying a significantly increased RV to left ventricular basal diameter ratio of 2.5, a dilated right atrium, and moderate tricuspid and pulmonary regurgitation. There was also evidence of septal flattening, and the estimated pulmonary artery systolic pressure exceeded 50 mmHg. No evidence of RV hypertrophy noted on echocardiography. These findings are consistent with PH secondary to tumour-induced vascular obstruction, leading to acute RV pressure overload and myocardial strain, supported by both metabolic evidence from the 18F-FDG PET/CT and functional evidence from the echocardiography.
RV myocardial strain represents a specific type of myocardial metabolic stress that occurs in response to acute pressure overload, most commonly associated with conditions like pulmonary embolism or chronic PH.[1] This case highlights a rare but clinically significant variant associated with malignancy, where tumour-induced pulmonary artery obstruction led to acute RV strain. In this case, the diffuse FDG uptake in RV reflects a well-documented metabolic shift from fatty acid oxidation to glucose utilisation under pressure overload conditions.[2,3] In addition, echocardiographic findings, such as RV dilation and septal flattening, confirm the mechanical consequences of this metabolic adaptation.[4] Small cell lung cancer has a particular tendency for vascular involvement, with Pancoast tumours showing direct vascular invasion in up to 25% of cases.[5] The resulting PH due to tumour-related vascular compression carries important prognostic implications, as the RV has a limited capacity to adapt to acute increases in afterload.[6,7] The metabolic changes observed on 18F-FDG-PET scans occur before any structural remodeling, suggesting that these changes could be an early biomarker for RV dysfunction in these patients.[8]
This case emphasises the dual diagnostic role of 18F-FDG PET/CT in oncology practice: while primarily used for tumour staging, it can also detect metabolic evidence of cardiac strain. Early identification of this pattern may help guide interventions such as targeted pulmonary vasodilators or tumour debulking;[9] however, optimal management strategies require further investigation.
Author contribution:
HG: Conceptualised the study, interpreted the imaging findings, and drafted the manuscript;. SAK, SN, and YSM: Contributed to patient evaluation, data acquisition, and literature review; DH: Supervised the work,critically revised the manuscript, and approved the final version. All authors reviewed and approved the final manuscript.
Ethical approval:
Institutional Review Board approval is not required.
Conflicts of interest:
There are no conflicts of interest.
Declaration of patient consent:
The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient has given consent for their images and other clinical information to be reported in the journal. The patient understand that the patient's names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Use of artificial intelligence (AI)-assisted technology for manuscript preparation:
The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.
Financial support and sponsorship: Nil.
References
- 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: The joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). International Society for Heart and Lung Transplantation (ISHLT) Eur Heart J. 2016;37:67-119.
- [CrossRef] [PubMed] [Google Scholar]
- Relation between right ventricular function and increased right ventricular [18F] fluorodeoxyglucose accumulation in patients with heart failure. Circ Cardiovasc Imaging. 2011;4:59-66.
- [CrossRef] [PubMed] [Google Scholar]
- Increased [18F] fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol. J Am Coll Cardiol. 2005;45:1849-55.
- [CrossRef] [PubMed] [Google Scholar]
- Anatomy, function, and dysfunction of the right ventricle: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73:1463-82.
- [CrossRef] [PubMed] [Google Scholar]
- Pancoast tumours: Characteristics and preoperative assessment. J Thorac Dis. 2014;6(Suppl 1):S108-15.
- [Google Scholar]
- Comorbidity in small cell lung cancer: prognostic impacts of hypertension/coronary artery disease, diabetes mellitus, and chronic obstructive pulmonary disease. Cancer Invest. 2024;42:21-33.
- [CrossRef] [PubMed] [Google Scholar]
- Tumoral pulmonary hypertension. Eur Respir Rev. 2019;28:180065.
- [CrossRef] [PubMed] [Google Scholar]
- The ratio of (18)F-FDG activity uptake between the right and left ventricle in patients with pulmonary hypertension correlates with the right ventricular function. Clin Nucl Med. 2014;39:426-30.
- [CrossRef] [PubMed] [Google Scholar]
- Early detection and management of pulmonary arterial hypertension. Eur Respir Rev. 2012;21:306-12.
- [CrossRef] [PubMed] [Google Scholar]

